Jun Chen
Corporate Officer/Principal bei VISEN Pharmaceuticals
Aktive Positionen von Jun Chen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VISEN Pharmaceuticals
VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01.04.2021 | - |
Karriereverlauf von Jun Chen
Ehemalige bekannte Positionen von Jun Chen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Novo Nordisk China
Novo Nordisk China Medical SpecialtiesHealth Technology Part of Novo Nordisk Fonden, Novo Nordisk China is a Chinese global biopharmaceutical company headquartered in Copenhagen, Denmark. The company is based in Beijing, China. The company's goal is to drive change in order to overcome serious chronic diseases such as diabetes, obesity, rare blood diseases, and endocrine disorders. | Vertrieb & Marketing | 01.01.2002 | 01.04.2016 |
Statistik
International
China | 3 |
Operativ
Corporate Officer/Principal | 1 |
Sales & Marketing | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Novo Nordisk China
Novo Nordisk China Medical SpecialtiesHealth Technology Part of Novo Nordisk Fonden, Novo Nordisk China is a Chinese global biopharmaceutical company headquartered in Copenhagen, Denmark. The company is based in Beijing, China. The company's goal is to drive change in order to overcome serious chronic diseases such as diabetes, obesity, rare blood diseases, and endocrine disorders. | Health Technology |
VISEN Pharmaceuticals
VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Health Technology |